| ₹ crore | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Revenue | 907 | 930 | −2.4% |
| EBITDA | 186 | 218 | −14.8% |
| EBITDA margin | 20.5% | 23.5% | −3.0 pts |
| Profit before tax | 210 | 238 | −11.6% |
| Net profit | 157 | 178 | −11.5% |
| EPS | ₹3.14 | ₹3.56 | −11.8% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 16,744 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 925 | 956 | 495 | 392 | 286 | ||
| 4.0 | 4.1 | 3.9 | 3.0 | 0.0 | ||
| 1.5 | 1.5 | 19.1 | 0.5 | 0.0 | ||
| 15,825 | — | — | — | — | ||
| 3,222 | 3,238 | 3,149 | 2,844 | 3,511 | ||
| — | +2.9% | +10.7% | −19.0% | — | ||
| 653 | 671 | 632 | 475 | 667 | ||
| 20.3% | 20.7% | 20.1% | 16.7% | 19.0% | ||
| 585 | 605 | 566 | 412 | 615 | ||
| 559 | 543 | 506 | 370 | 502 | ||
| 17.3% | 16.8% | 16.1% | 13.0% | 14.3% | ||
| ₹11.20 | ₹10.88 | ₹10.13 | ₹7.40 | ₹10.06 | ||
| — | +7.4% | +36.8% | −26.4% | — | ||
| — | 446 | 453 | 760 | 389 | ||
| — | −44.2 | −29.5 | −68.3 | −120 | ||
| 401 | 401 | 423 | 692 | 270 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 16,743.9 | |
| - Cash, Equiv & ST Investments | 285.7 | 392.4 | 495.5 | 956.1 | 924.8 | |
| + Minority Interest | 0.0 | 3.0 | 3.9 | 4.1 | 4.0 | |
| + Total Debt | 0.0 | 0.5 | 19.1 | 1.5 | 1.5 | |
| Enterprise Value | — | — | — | — | 15,824.5 | |
| Revenue | 3,511.0 | 2,843.9 | 3,148.5 | 3,238.3 | 3,222.4 | |
| Growth %, YoY | — | -19.0 | +10.7 | +2.9 | — | |
| EBITDA | 666.6 | 474.6 | 632.1 | 670.9 | 652.7 | |
| Margin % | 18.99 | 16.69 | 20.07 | 20.72 | 20.26 | |
| EBIT | 614.7 | 412.4 | 566.0 | 604.7 | 584.6 | |
| Net Income | 502.2 | 369.7 | 506.4 | 543.0 | 559.0 | |
| Margin % | 14.30 | 13.00 | 16.09 | 16.77 | 17.35 | |
| EPS, Adj (current shares) | 10.06 | 7.40 | 10.13 | 10.88 | 11.20 | |
| Growth %, YoY | — | -26.4 | +36.8 | +7.4 | — | |
| Cash from Operations | 389.4 | 759.8 | 452.7 | 445.5 | — | |
| Capital Expenditures | -119.9 | -68.3 | -29.5 | -44.2 | — | |
| Free Cash Flow | 269.5 | 691.5 | 423.3 | 401.3 | 401.3 | |
Prices at the 29 October 2026 close · figures from the company's filings with NSE
Sumitomo Chemical India (NSE: SUMICHEM) had a market capitalisation of ₹16,567 crore at the 29 October 2026 close (₹331.90 a share), a PE ratio of 29.6 on the last four quarters' profit and a price-to-book ratio of 4.48. In FY26 its consolidated net profit was ₹543 crore on revenue of ₹3,238 crore; in Q2 FY27 (July–September 2026) it was ₹157 crore, down 11.5% year on year. Its debt-to-equity ratio was 0.00 on 30 September 2026. Promoters held 75.00% of the shares on 30 September 2026.
Sumitomo Chemical India's PE ratio is 29.6 at the 29 October 2026 close (₹331.90 a share): a market capitalisation of ₹16,567 crore divided by consolidated net profit of ₹559 crore over the last four quarters (Q3 FY26 to Q2 FY27). On FY26 net profit (₹543 crore) it is 30.5.
Sumitomo Chemical India's net worth — shareholders' equity in its consolidated balance sheet — was ₹3,697 crore on 30 September 2026, up 15.6% from ₹3,197 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹16,567 crore at the 29 October 2026 close.
Sumitomo Chemical India's book value per share was ₹74.06 on 30 September 2026: shareholders' equity of ₹3,697 crore divided by the 49.91 crore shares in issue, up 15.6% from ₹64.06 a year earlier. The share price at the 29 October 2026 close was ₹331.90.
Sumitomo Chemical India's price-to-book (PB) ratio is 4.48 at the 29 October 2026 close: a market capitalisation of ₹16,567 crore divided by shareholders' equity (book value) of ₹3,697 crore on 30 September 2026. That is a book value of ₹74.06 per share against a share price of ₹331.90.
In FY26, Sumitomo Chemical India's return on equity (ROE) was 17.3% and its return on capital employed (ROCE) was 18.6%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 18.9% and ROCE 20.5%.
Sumitomo Chemical India's dividend yield is 0.39% at the 29 October 2026 close: dividends of ₹1.30 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹331.90. They were ₹1.30 on 17 July 2026.
Sumitomo Chemical India's market capitalisation was ₹16,567 crore at the 29 October 2026 close: 49.91 crore shares at ₹331.90 each.
No. Sumitomo Chemical India had borrowings of ₹1.4 crore on 30 September 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.00. Its cash and current investments were ₹927 crore, so it held net cash of ₹925 crore.
Sumitomo Chemical India's basic earnings per share (EPS) were ₹10.88 in FY26, against ₹10.13 in FY25. Over the last four quarters (Q3 FY26 to Q2 FY27) they add up to ₹11.19.
Sumitomo Chemical India's debt-to-equity ratio was 0.00 on 30 September 2026: borrowings of ₹1.4 crore against total equity of ₹3,701 crore. A year earlier, on 30 September 2025, it was 0.01.
Promoters held 75.00% of Sumitomo Chemical India on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
In FY26, Sumitomo Chemical India generated ₹446 crore of cash from operations and spent ₹44.2 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹401 crore. In FY25 it was ₹423 crore.
In 2026, Sumitomo Chemical India has declared one dividend: ₹1.30 with record date 17 July 2026.
Sumitomo Chemical India's latest results are for Q2 FY27 (July–September 2026), filed on 26 October 2026: consolidated net profit ₹157 crore, down 11.5% from ₹178 crore in Q2 FY26; revenue from operations ₹907 crore, down 2.4% year on year.
In FY26 (April 2025–March 2026), Sumitomo Chemical India's consolidated net profit was ₹543 crore, up 7.4% from ₹505 crore in FY25, on revenue from operations of ₹3,238 crore (up 2.9%). Over three years, from FY23, net profit was up 8.1%.
On 30 September 2026, Sumitomo Chemical India's shares were held by promoters 75.00%, foreign portfolio investors (FII/FPI) 2.89%, domestic institutions (DII) 9.69% (including mutual funds at 7.68%) and retail and other non-institutional investors 12.42%. Over the year, FII holding was down 0.76 percentage points from 3.65% and DII holding was up 1.22 percentage points from 8.47%.
On FY26 consolidated figures, against Bayer Cropscience and PI Industries: Sumitomo Chemical India's operating margin of 18.7% is the second highest of the three (Bayer Cropscience 13.7%, PI Industries 19.3%; peer average 16.5%); its return on equity of 17.3% is the second highest of the three (Bayer Cropscience 23.7%, PI Industries 12.2%; peer average 17.9%).
In FY26, Sumitomo Chemical India earned net profit of ₹543 crore on revenue of ₹3,238 crore, against ₹689 crore on ₹5,675 crore for Bayer Cropscience. Sumitomo Chemical India's operating margin was 18.7% (Bayer Cropscience 13.7%) and its return on equity 17.3% (Bayer Cropscience 23.7%).
Sumitomo Chemical India has reported Q2 FY27. Its next results, for Q3 FY27 (October–December 2026), are due by 14 February 2027 under SEBI's 45-day rule; the company notifies the board-meeting date at least two working days before.
From Sumitomo Chemical India's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.